Lineage Cell Therapeutics Inc (LCTX)

[terry hallinan]

From teleconference:

Our ARVO data, along with the presentation of the Cell and Gene Therapy Summit at [indiscernible] ARVO were well received by those in attendance. During the conference, we were posted by several therapeutic area experts who complimented us on the exciting data. The main takeaway from these interactions was that there is a high level of excitement for and anticipation of the functional assessments and measurements of cohort 4 we may see before year-end.

Yeah, I would expect the "postings" would be enthusiastic but to date the subjects are all functionally blind before and after treatment or we would have heard otherwise.

The more exciting news may come from the less severely damaged eyes of volunteers in cohort 4.

Meanwhile the CE mark has been approved for the Renevia treatment of AIDS patients that I regard as a very big deal.

However Dr. West may prosper or suffer at AgeX, I have high hope for BTX.

Admittedly I have had to accommodate myself to much severe disappointment in R&D.

Best, Terry